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Astigmatism is a commonly occurring refractive error 
that leads to impaired visual acuity if uncorrected and is 
a risk factor for amblyopia [1-4]. The two major sources 
of refractive astigmatism in the human eye are the cornea 
and the crystalline lens. In emmetropic eyes, a low degree 
of with-the-rule (WTR) corneal astigmatism is typically 
compensated by a low degree of against-the-rule (ATR) 
lenticular astigmatism [5]. For individuals with higher levels 
of refractive astigmatism, corneal astigmatism is usually the 
major contributor, while lenticular astigmatism is within the 
normal range [6].
Studies in chicks have recently shown that the eye can 
compensate for experimentally induced astigmatism through 
the alteration of corneal curvature [7]. This suggests that 
the reduction in innate astigmatism seen during infancy in 
children occurs via active emmetropization [8]. Potential 
reasons why astigmatism still arises despite the presence 
of an emmetropization system include (a) astigmatism of 
too high a degree to be compensated within the juvenile 
period, (b) astigmatism outside the “operating range” of the 
emmetropization system, for example, producing a retinal 
image that is not detected as being caused by astigmatism 
or that arises at an age beyond that at which emmetropiza-
tion normally acts, and (c) a failure of the emmetropization 
response [2].
Several lines of evidence support the role of genetics in 
the etiology of astigmatism. First, epidemiology studies have 
shown marked differences in the prevalence of astigmatism 
across ethnic groups, even after accounting for differences 
in spherical refractive error. For instance, 78% of native 
American Tohono O’odham children aged 0–8 have at least 1 
diopter (D) of corneal astigmatism, and in Australian children 
aged 12, at least 1 D of corneal astigmatism was found in 19% 
of European individuals versus 50% of East Asian individuals 
[9,10]. Second, corneal and refractive astigmatism have been 
reported as being moderately/highly heritable (heritability 
of 0.3–0.6) in twin studies [11,12]. Third, a genetic segrega-
tion study in families with high-degree astigmatism found 
evidence of Mendelian inheritance [13]. Finally, genetic 
association studies have identified specific genetic variants 
associated with susceptibility to either refractive and/or 
corneal astigmatism [14-17]. Despite these latter studies, our 
understanding of the genetic contribution to astigmatism has 
lagged behind that of spherical refractive errors, for which 
dozens of genetic variants have been discovered [18-21].
Previously, the Consortium for Refractive Error and 
Myopia (CREAM) reported a genome-wide association 
study (GWAS) of refractive astigmatism that examined 
approximately two million genetic markers in 45,931 indi-
viduals [17]. Only a single marker reached genome-wide 
significance (rs1401327 in the NRXN1 gene, p=3.92E−8). 
Reasoning that the paucity of genome-wide significant hits 
in the previous CREAM study may have been due to pheno-
typic uncertainty when studying refractive astigmatism that 
arose from the combination of both corneal and lenticular 
influence, CREAM has now undertaken a GWAS of corneal 
astigmatism. Fan et al. [16] performed a GWAS of corneal 
astigmatism using a discovery sample of 4,254 East Asian 
individuals and identified a genome-wide significant locus 
near the PDGFRA gene. In view of the success of the Fan 
et al. [16] study, the current analysis has adopted the same 
phenotype definition.
Purpose: To identify genes and genetic markers associated with corneal astigmatism.
Methods: A meta-analysis of genome-wide association studies (GWASs) of corneal astigmatism undertaken for 14 
European ancestry (n=22,250) and 8 Asian ancestry (n=9,120) cohorts was performed by the Consortium for Refractive 
Error and Myopia. Cases were deined as having >0.75 diopters of corneal astigmatism. Subsequent gene-based and gene-
set analyses of the meta-analyzed results of European ancestry cohorts were performed using VEGAS2 and MAGMA 
software. Additionally, estimates of single nucleotide polymorphism (SNP)-based heritability for corneal and refractive 
astigmatism and the spherical equivalent were calculated for Europeans using LD score regression.
Results: The meta-analysis of all cohorts identiied a genome-wide signiicant locus near the platelet-derived growth 
factor receptor alpha (PDGFRA) gene: top SNP: rs7673984, odds ratio=1.12 (95% CI:1.08–1.16), p=5.55×10−9. No other 
genome-wide signiicant loci were identiied in the combined analysis or European/Asian ancestry-speciic analyses. 
Gene-based analysis identiied three novel candidate genes for corneal astigmatism in Europeans—claudin-7 (CLDN7), 
acid phosphatase 2, lysosomal (ACP2), and TNF alpha-induced protein 8 like 3 (TNFAIP8L3).
Conclusions: In addition to replicating a previously identiied genome-wide signiicant locus for corneal astigmatism 
near the PDGFRA gene, gene-based analysis identiied three novel candidate genes, CLDN7, ACP2, and TNFAIP8L3, 
that warrant further investigation to understand their role in the pathogenesis of corneal astigmatism. The much lower 
number of genetic variants and genes demonstrating an association with corneal astigmatism compared to published 
spherical equivalent GWAS analyses suggest a greater inluence of rare genetic variants, non-additive genetic effects, 
or environmental factors in the development of astigmatism.
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Table 1. SubjecT demographicS of parTicipaTing cream STudy groupS.
Study Ancestry N (cases/controls) %Female Age (years) Corneal astigmatism (D)Mean (SD) Median (IQR) Range
ALSPAC European 2279(985/1294) 53.1 15.5 (0.3) 0.683 (0.469–0.959) 0.000–5.680
BMES European 1238(720/518) 41.8 73.3 (7.6) 0.863 (0.565–1.295) 0.155–8.615
EPIC European 857(456/401) 58.5 68.7 (7.4) 0.780 (0.527–1.152) 0.075–3.997
FITSA European 127(62/65) 100 67.9 (3.1) 0.733 (0.530–1.033) 0.270–2.020
GenerationR European 2071(981/1090) 49.9 6.09 (0.4) 0.725 (0.480–0.995) 0.000–3.370
GHS 11 European 2398(1003/1395) 48.7 55.9 (10.8) 0.65 (0.400–0.950) 0.050–4.350
GHS 21 European 851(383/468) 50.9 55.1 (10.8) 0.65 (0.450–1.000) 0.050–3.800
RAINE European 1028(407/621) 50.9 20.0 (0.4) 0.649 (0.445–0.905) 0.280–2.440
Rotterdam-I European 5537(2064/3473) 59.3 69.5 (9.2) 0.601 (0.334–1.007) 0.000–9.663
Rotterdam-II European 1982(633/1349) 53.8 64.8 (8.0) 0.539 (0.294–0.884) 0.000–6.789
Rotterdam-III European 2925(1180/1745) 56.2 57 (6.9) 0.618 (0.356–1.019) 0.000–4.869
OGP-A2 European 92(37/55) 44.6 16.0 (4.5) 0.682 (0.512–0.942) 0.185–3.070
OGP-B2 European 446(181/265) 43.7 50.6 (15.4) 0.650 (0.430–0.970) 0.130–4.240
TwinsUK European 419(201/218) 92.7 64 (10.5) 0.729 (0.476–1.105) 0.000–5.432
BES-610K3 Asian 553 (240/313) 65.6 62.1 (8.4) 0.666 (0.407–1.056) 0.000–3.620
BES-OmniE3 Asian 469 (208/261) 60.1 64.7 (9.5) 0.676 (0.429–1.016) 0.000–5.082
SCES-610K3 Asian 1745 (787/958) 48.7 57.6 (9.0) 0.703 (0.476–1.060) 0.109–5.868
SCES-OmniE3 Asian 545 (257/288) 48.6 59.2 (8.8) 0.723 (0.470–1.065) 0.117–5.404
SCORM Asian 947 (768/179) 48.6 10.8 (0.8) 1.205 (0.851–1.624) 0.138–3.911
SIMES Asian 1778 (750/1028) 51.7 59.5 (10.8) 0.662 (0.432–1.016) 0.078–5.618
SINDI Asian 2261 (814/1447) 48.6 56.5 (9.1) 0.614 (0.411–0.912) 0.115–4.727
STARS Asian 822 (525/297) 50.0 38.5 (5.3) 1.000 (0.625–1.380) 0.125–3.875
1Association tests were undertaken separately for samples recruited in different waves.2Association tests were undertaken separately for different age strata (stratum A, age >3 
and <25 years; stratum B, age ≥25 years). 3Association tests were undertaken separately for samples genotyped on different platforms.
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METHODS
The research study followed an analysis plan that was agreed 
upon by members of CREAM before starting work. This plan 
was designed to standardize methods across participating 
CREAM groups and to set timelines for the completion 
of specific tasks. All research groups known to CREAM 
with relevant genotype and phenotype data were invited to 
contribute to the study. Ethical approval for the study was 
obtained locally for each CREAM study group, and partici-
pants gave informed consent. The research was carried out 
in accordance with the tenets of the Declaration of Helsinki.
Study sample: The demographics of the participating study 
groups are shown in Table 1. The participants comprised 
22,250 European individuals from 14 studies and 9,120 
Asian individuals from 8 studies. There were 5,470 European 
participants and 947 Asian participants aged <25 years.
Phenotype definition: Following Fan et al. [16], cases were 
defined as participants with corneal astigmatism >0.75 D, 
and controls were defined as those with corneal astigmatism 
≤0.75 D. Corneal astigmatism was averaged between the two 
eyes, except for participants with data available for only one 
eye. For the conversion of keratometry readings in millime-
ters to diopters, we used a conversion factor of 332 divided 
by the K-reading in mm [22].
Phenotyping, genotyping, and genetic imputation: Anterior 
corneal curvature was measured using keratometry (the 
keratometer used by each CREAM study group is listed in 
Appendix 1), and corneal astigmatism was calculated as the 
difference in curvature between the steepest and flattest 
meridians. Participants known to have keratoconus, corneal 
scarring, ocular surgery, or any corneal/ocular condition 
that would impair keratometry were excluded from the 
analysis. DNA samples were extracted from blood or saliva 
and genotyped on a high-density single nucleotide polymor-
phism (SNP) platform, as previously described [17]. Each 
CREAM study group imputed non-genotyped markers from 
an ancestry-matched reference panel from the 1000 Genomes 
Project [17] using IMPUTE2 [23] or Minimac [24]. Quality-
control filtering was performed in accordance with standard 
GWAS practices [25]. In general, markers with per-study 
missingness <0.95, minor allele frequency (MAF) <0.05, 
or a Hardy–Weinberg disequilibrium p value <1×10−6 were 
excluded, along with samples with per-study missingness 
<0.95, extreme heterozygosity, sex mismatch, unaccounted 
for relatedness, or outlying ancestry [25]. Poorly imputed 
markers (IMPUTE2 info ≤0.5 or Minimac Rsq ≤0.5) were 
also excluded.
Genome-wide association studies and meta-analyses: Tests 
of association between corneal astigmatism case/control 
status and SNP genotype were performed genome-wide by 
each participating CREAM study group. The analysis was 
performed using PLINK [26] for marker genotypes coded 0, 
1, or 2 or using mach2dat [24] or ProbABEL [27] for marker 
genotypes coded as imputed dosage on the scale 0–2. Age 
and sex were included as a continuous and a binary covariate, 
respectively. The first five major principal components were 
also included as continuous covariates if there was evidence 
of population stratification from Q-Q plots or the genomic 
control inflation factor (λ
GC
). For samples of related individ-
uals, the analysis method took account of genetic background 
by treating this as a random effect in the analysis model. Tests 
of association were conducted separately for participants of 
European ancestry and participants of Asian ancestry and for 
younger (age >3 and <25) and older (age ≥25) participants.
Summary statistics from the participating CREAM 
study groups were submitted to a central site for meta-
analysis. Using the approach implemented in easyQC [28], 
the summary statistics were evaluated by examining quality 
control plots and metrics, including effect allele frequency 
(EAF) plots, p value versus z-score (P-Z) plots, standard error 
versus sample size (SE-N) plots, effect size (odds ratio) distri-
butions, and genomic control inflation factors. Queries were 
resolved by discussion with study groups analysts, and, where 
indicated, imputation or association testing was repeated.
Meta-analyses were performed separately for the 
four demographic strata—younger/older, European/Asian 
ancestry individuals. Fixed effects, standard error-weighted 
meta-analysis [29] was performed initially, followed by a 
random effects meta-analysis [30] for highly associated 
markers showing excessive between-study heterogeneity of 
I2>0.5, where I2 is a measure of heterogeneity derived from 
Cochran’s Q statistic [31]. A p value of 5×10−8 was adopted for 
declaring genome-wide significant association in the GWAS 
meta-analyses [32]. Regional association plots were created 
using LocusZoom [33]. Conditional analysis was performed 
on GWAS meta-analysis summary statistics using GCTA-
COJO [34].
Gene-based tests and pathway analysis: Two gene-based 
tests, VEGAS2 [35] and MAGMA [36], were used to explore 
whether specific genes were enriched with strongly associ-
ated variants in the GWAS meta-analysis of older European 
individuals. Attention was restricted to the older European 
samples because gene-based testing relies on consistent 
patterns of linkage disequilibrium (LD) across genes, and 
the sample size was larger for the European meta-analysis 
compared to that for the Asian cohorts. Markers within 50 
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kb upstream and downstream of a gene were included in 
the gene-based tests, with the aim of detecting variants that 
altered the expression level of genes. The gene-based testing 
using MAGMA was repeated using an extended flanking 
region of 200 kb upstream and downstream of genes.
VEGAS2 [35] uses a fast approximation of a permuta-
tion-based test to determine whether genes are enriched for 
highly associated markers and makes use of LD information 
from an ancestry-matched reference panel to account for 
association signals shared by markers in LD. The test was 
implemented to analyze all markers in each gene. MAGMA 
[36] overcomes the low statistical power inherent when a gene 
contains many markers, some of which may be in strong LD, 
by first carrying out a principal components analysis (PCA) 
for the markers in each gene and then carrying out a per-
gene linear regression analysis using the PCA eigenvectors 
as predictor variables. High statistical power is attained by 
limiting the regression to the major eigenvalues. Permutation-
based p values are calculated to account for the use of a binary 
outcome as the dependent variable in the linear regression 
analysis [36].
Gene-set “pathway analysis” was also performed using 
MAGMA [36]. This was performed using a competitive 
approach whereby the test statistics for all genes within a 
gene set were combined to form a joint association statistic. 
This statistic was compared against that for all other genes not 
in that set while accounting for the number of SNPs within 
each gene, gene density, and differential sample size (unequal 
sample size contributing to each gene) [36]. Gene sets were 
defined using the Molecular Signatures Database (MSigDB) 
[37]. Gene definitions and their respective association signals 
for genes contributing to gene sets were taken from the 
MAGMA gene-based analyses with the aim of identifying 
potential biologic processes that may be influenced by these 
variants.
Shared genetic contribution to traits: LD score regression 
[38,39] was used to quantify the degree of shared genetic 
contribution between corneal astigmatism and two related 
traits, refractive astigmatism and mean spherical equivalent 
refractive error. GWAS summary statistics for refractive 
astigmatism and for spherical equivalent refractive error were 
obtained from previous CREAM studies [17,18]. LD score 
regression utilizes LD information from an ancestry-matched 
reference panel and requires large sample sizes; therefore, 
analyses were limited to European GWAS samples. Specifi-
cally, LD score regression was performed using the LDSC 
program [38,39] for variants present in the HapMap3 CEU 
reference panel with MAF ≥0.05. The prevalence of corneal 
astigmatism (defined as an amount >0.75 D) in the general 
population was taken as 42%, which was calculated as the 
average for the European ancestry population-based studies 
contributing to this meta-analysis. LD score regression 
remains valid when two traits are measured in overlapping 
samples [39], which was the case for these CREAM GWAS 
samples.
RESULTS
Meta-analysis of genome-wide association studies: Meta-
analyses were performed using a fixed effects model for 
approximately six million genetic variants (approximately 
5,500,000 SNPs and 380,000 indels) in each of the four 
ancestry/age strata (younger European, older European, 
Figure 1. Manhattan plot showing 
most strongly associated markers 
in the GWAS ixed-effects meta-
analysis for European and Asian 
participants of all ages combined 
(n=31,375). Red line: p=5×10−8, blue 
line: p=1×10−5.
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Figure 2. Q-Q plot for the GWAS 
fixed-effects meta-analysis for 
European and Asian participants of 
all ages combined (n=31,375).
Figure 3. Region plot for the most 
strongly associated region in the 
GWAS ixed-effects meta-analysis 
for European and Asian participants 
of all ages combined (n=31,375).
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Table 2. moST STrongly aSSociaTed marker in each region in The gWaS meTa-anal-
ySiS of all SampleS (europeanS and aSianS of all ageS combined). 
SNP Chr Pos Effect allele Other allele EAF OR (95%CI) P value Nearest gene
rs7673984 4 55,088,761 T C 0.22 1.12 (1.08–1.16) 5.55×10−9 PDGFRA
rs34751092 4 24,129,037 A G 0.28 1.09 (1.05–1.13) 6.07×10−7 PPARGC1A
rs630203 5 141,444,269 T G 0.74 0.92 (0.88–0.95) 8.83×10−7 MRPL11P2
rs75607298 8 128,611,496 A G 0.72 1.14 (1.08–1.21) 2.28×10−6 CASC11
rs62401199 6 43,813,341 T C 0.14 1.15 (1.09–1.22) 3.29×10−6 LINC01512
rs753992 11 47,349,846 A G 0.29 0.91 (0.87–0.95) 3.48×10−6 MADD
rs3214101 11 114,009,408 A T 0.68 1.08 (1.05–1.12) 3.75×10−6 ZBTB16
rs10985068 9 123,629,724 C G 0.12 1.13 (1.07–1.19) 5.87×10−6 PHF19
rs62128379 2 26,960,055 T C 0.85 1.13 (1.07–1.19) 6.00×10−6 KCNK3
rs9939114 16 84,023,972 A G 0.05 0.54 (0.41–0.70) 6.01×10−6 NECAB2
rs60083876 7 34,228,819 A T 0.95 1.31 (1.17–1.48) 6.53×10−6 BMPER
rs859362 1 175,495,090 T C 0.19 1.10 (1.05–1.15) 7.14×10−6 TNR
rs11775037 8 108,317,615 A G 0.20 1.10 (1.05–1.14) 7.31×10−6 ANGPT1
rs7036824 9 96,149,894 T C 0.94 0.83 (0.77–0.90) 8.78×10−6 C9orf129
rs142168171 7 71,253,651 I R 0.09 1.37 (1.19–1.57) 9.14×10−6 CALN1
rs7278671 21 41,047,876 A G 0.51 0.93 (0.90–0.96) 9.31×10−6 B3GALT5
rs191640722 1 119,264,997 C G 0.09 0.87 (0.82–0.93) 9.53×10−6 LOC100421281
rs36107906 2 44,162,800 D R 0.29 1.09 (1.05–1.13) 9.61×10−6 LRPPRC
rs4896367 6 138,807,281 T C 0.72 1.09 (1.05–1.14) 9.75×10−6 NHSL1
rs35587414 1 153,174,958 T C 0.15 1.13 (1.07–1.20) 9.79×10−6 LELP1
EAF=effect allele frequency, OR=odds ratio.
Figure 4. Forest plot and summary 
table for lead variant rs7673984 
across all cohorts. Studies listed 
above the dotted line are new 
cohorts not included in the only 
prior GWAS for corneal astig-
matism [16]. EAF=effect allele 
frequency. (Note that rs7673984 
was excluded from the Rotterdam-
I cohort analysis during quality 
control iltering).
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younger Asian, and older Asian). However, none of the 
markers had a p value below the pre-determined threshold of 
5×10−8 used to declare genome-wide significance (Appendix 
2, Appendix 3, Appendix 4, Appendix 5, Appendix 6, and 
Appendix 7). Therefore, to increase power, a meta-analysis 
was performed using data for all four ancestry/age strata, 
under the assumption that the genetic determinants of 
corneal astigmatism are consistent across ancestry groups 
and lifespan. This yielded 49 markers with p values <5×10−8, 
all of which were located in a narrow interval on chromo-
some 4 close to the PDGFRA gene (Figure 1, Figure 2, and 
Figure 3). This locus has previously been identified in GWAS 
analyses for corneal astigmatism [16], refractive astigmatism 
[17], and corneal curvature [15,40,41]. Table 2 lists the most 
strongly associated marker in each region showing sugges-
tive association, defined as a region with at least one marker 
with p<1×10−5. Both the European and Asian meta-analyses 
contributed to the association signal at the PDGFRA locus; 
the most strongly associated marker, rs7673984, had an effect 
size (odds ratio) of OR=1.15 (95% CI:1.07–1.24; p=1.76×10−4) 
in Asians, OR=1.11 (95% CI:1.06–1.16; p=5.64×10−6) in Euro-
peans, and OR=1.12 (95% CI:1.08–1.16; p=5.55×10−9) in the 
meta-analysis of Asians and Europeans. The association of 
rs7673984 in the individual cohorts examined is summarized 
in Figure 4. Conditional analysis using GCTA-COJO yielded 
no additional association signals at the PDGRFA locus inde-
pendent of rs7673984.
Gene-based analyses: To explore whether specific genes were 
enriched for markers with low p values in the GWAS meta-
analysis, we performed gene-based tests using VEGAS2 [35] 
and MAGMA [36]. These programs use different approaches 
to test for such enrichment (see Methods). Due to the require-
ment for an ancestry-matched reference panel, analyses were 
conducted using the results of a GWAS meta-analysis of 
European samples of all ages (however, similar results were 
obtained when attention was restricted to the meta-analysis of 
older Europeans). The 10 most strongly associated genes from 
the VEGAS2 and MAGMA analyses are shown in Appendix 
8 and Appendix 9. There was a high degree of overlap 
between the results of the two programs, with the genes ACP2, 
CLDN7, ELP5, and CTDNEP1 showing the strongest associa-
tion in both analyses (Appendix 8 and Appendix 9). In the 
MAGMA gene-based test, these four genes and TNFAIP8L3 
achieved p<0.05 after stringent Bonferroni correction, 
whereas this was not the case for VEGAS (Appendix 8 and 
Appendix 9). A further exploratory gene-based analysis that 
included markers up to 200 kb upstream or downstream of 
each gene—an approach that has been successful for certain 
traits [42]—failed to identify any additional genes associated 
with corneal astigmatism.
Pathway analysis: As biologic processes tend to involve 
multiple genes, a gene-set analysis was performed with 
MAGMA [36] using the gene-based analysis results for the 
European samples. Gene-set analyses seek to identify poten-
tial biologic mechanisms enriched for genes with markers 
attaining low p values in the GWAS meta-analysis. However, 
no gene sets were identified as demonstrating a greater level 
of association with corneal astigmatism than would be 
expected by chance (when flanking regions of either ±50 kb 
or ±200 kb upstream or downstream of genes were tested).
SNP heritability and genetic correlation between traits: 
LD score regression was used to quantify the heritability 
explained by commonly occurring genetic variants (“SNP 
heritability”) and the degree of genetic sharing between 
corneal astigmatism and two related traits, refractive 
Table 3. Snp-heriTabiliTy eSTimaTed uSing ld Score regreSSion (europeanS only).
Trait No. of Markers SNP-heritability (SE) P value
Corneal Astigmatism 1,024,525 0.0555 (0.0381) 0.15
Refractive Astigmatism 1,056,658 0.0136 (0.0218) 0.53
Mean Spherical Equivalent 1,056,658 0.2326 (0.0175) 2.60×10−40
Table 4. geneTic correlaTionS beTWeen pairS of refracTive error TraiTS in SampleS of euro-
pean anceSTry from The cream conSorTium (uSing ld Score regreSSion).
Trait Pairs No. of Markers Genetic Correlation (SE) P value
RA and CA 934,512 0.2327 (0.703) 0.7406
MSE and CA 1,024,525 −0.0238 (0.1599) 0.8815
RA and MSE 1,056,658 0.7732 (0.6504) 0.2345
RA=refractive astigmatism, CA=corneal astigmatism, MSE=mean spherical equivalent. P values refer to likelihood of non-zero correla-
tion between traits.
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astigmatism and spherical equivalent refractive error (Table 3 
and Table 4). The SNP heritability (h2) estimates for corneal 
and refractive astigmatism (~5% and ~1%, respectively) 
were lower than for the spherical equivalent (~23%); indeed, 
the SNP heritability estimates for corneal and refractive 
astigmatism were not significantly different from zero. The 
genetic correlation estimates also had high standard errors 
and therefore yielded very imprecise estimates (Table 4). 
These hinted at a high genetic correlation between corneal 
astigmatism and the spherical equivalent; however, in view of 
the low SNP heritability estimate for the astigmatism traits, 
these findings imply that much larger sample sizes and/or a 
more homogeneous population sample is needed to obtain 
robust findings.
DISCUSSION
This GWAS for corneal astigmatism in a combined sample 
of Europeans and Asians identified a single genome-wide 
significant locus in the promoter region of the PDGFRA gene, 
replicating the previous discovery of this corneal astigmatism 
locus by Fan et al. [16] in a predominantly Asian sample. 
Therefore, despite a fourfold increase in sample size (n=31,370 
versus n=7,719) compared to the only previous GWAS meta-
analysis for corneal astigmatism [16], the standard, single-
marker GWAS analysis performed here did not identify any 
new loci. GWAS analyses for spherical equivalent and other 
morphological traits in equivalently sized samples have iden-
tified dozens of independent risk loci [18,19]. This paucity of 
GWAS loci for corneal astigmatism mirrors that observed in 
a previous large-scale GWAS for refractive astigmatism [17]. 
Our LD score regression-based SNP heritability estimates 
for corneal astigmatism (h2 ~5%) and refractive astigmatism 
(h2 ~1%)—the first ever estimates for these traits—were also 
much lower than those for the spherical equivalent (h2 ~23%), 
suggesting that common, additively acting SNPs make a 
relatively minor contribution to the development of astigma-
tism. In the study by Fan et al. [16] that originally identified 
the association between SNPs close to the PDGFRA gene 
and corneal astigmatism, the authors speculated that the 
underlying causal mechanism was common to populations 
of diverse ancestry and not specifically to those of Asian 
origin. This was based on the knowledge that their GWAS 
included individuals of Indian ancestry, who are more closely 
genetically related to Europeans than East Asians [16]. Our 
findings support this theory.
The association between PDGFRA SNPs and corneal 
astigmatism has been replicated in a previous study of Euro-
peans (n=1968) but not in another smaller study (n=1013) 
[41,43]. Variants at this locus were not associated with 
refractive astigmatism in GWAS meta-analyses of n=45,287 
participants [17] yet were associated with corneal curvature 
in an Asian sample [15] and with both corneal curvature and 
axial length (but not refractive error) in a European sample 
[41]. This complex series of findings suggests a role for 
PDGRFA in the regulation of eye size and corneal astigma-
tism; however, the underlying mechanism of action remains 
uncertain.
In contrast to the single-marker analyses, gene-based 
analysis did provide new insight into the genetic basis of 
corneal astigmatism, implicating the genes ACP2, CLDN7, 
CTDNEP1, ELP5, and TNFAIP8L3. Three of these five 
genes—CLDN7, CTDNEP1, and ELP5—are tightly clustered 
on chromosome 11, with their respective (gene-based) asso-
ciation signals sharing many variants in common. Therefore, 
a parsimonious interpretation is that only one of the genes 
has a causal association with astigmatism and that the other 
two genes are false-positive associations detected due to the 
signal from the causal gene. Of the three genes, CLDN7, 
which encodes the claudin-7 membrane protein [44], appears 
to be the most biologically plausible candidate. Claudins are 
responsible for tight junction formation and function [45], 
with claudin-7 being the subtype present in human corneal 
epithelium and endothelium [46]. Currently, how claudin-7 
may contribute to the development of corneal astigmatism 
is unclear. The acid phosphatase 2, lysosomal gene (ACP2) 
is located on chromosome 17 and codes for the beta subunit 
of the degradative enzyme, lysosomal acid phosphatase 
(LAP). Interestingly, LAP activity is enhanced in keratoconic 
corneas [47,48]. The TNFAIP8L3 gene located on chromo-
some 15 codes for TNF alpha-induced protein 8 like 3, which 
is preferentially expressed in secretory epithelial cells [49]. 
TNFAIP8L3 is implicated as a negative regulator of inflam-
mation (and carcinogenesis) through its role in TNFα and 
phospholipid signaling. Based on this evidence, the CLDN7, 
ACP2, and TNFAIP8L3 genes are promising susceptibility 
genes for corneal astigmatism. It is important to note that 
while the statistical support for the above three genes was 
much stronger in the MAGMA analysis than in the VEGAS2 
analysis, the two software programs similarly ranked the 
most strongly associated genes. This commonality between 
the MAGMA and VEGAS2 results provides greater confi-
dence that the findings are robust than would be the case for 
findings identified using either software program alone, as 
the statistical models and hypothesis tests used by the two 
programs differ, especially regarding the adjustment for vari-
ants in LD.
The strengths of this investigation are that data 
from multiple population samples were combined and 
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meta-analyzed and that gene-based and pathway-based 
follow-up analyses were undertaken to leverage new biologic 
insights into the genetics of astigmatism. The weaknesses 
were that although the samples included both European 
and Asian ancestry individuals, trans-ethnic meta-analysis 
[50] was not performed due to the small size of the Asian 
sample compared to the European sample and that the age 
spectrum of the participants was very broad. The latter point 
is an important consideration because astigmatism does not 
remain constant during life, with changes in both magnitude 
and orientation occurring with age [1]. For example, in child-
hood, astigmatism tends to be WTR, whereas in older adults 
this orientation typically changes to ATR. Our study design 
sought to overcome some of this variation by considering only 
the magnitude of corneal astigmatism (i.e., no consideration 
of astigmatism axis) and by using a case-control classification 
scheme, with the aim of reducing the impact of the subtle 
changes in astigmatism that commonly occur with age.
In conclusion, this GWAS meta-analysis for corneal 
astigmatism replicated the discovery of a genome-wide 
significant locus near the PDGFRA gene [16] and provided 
strong evidence that this locus is important in both Asians and 
Europeans (Figure 4). Three novel candidate genes, CLDN7, 
ACP2, and TNFAIP8L3, were identified using gene-based 
analyses that leveraged data from across genomic regions 
rather than from examining one genetic marker at a time. 
These novel genes warrant further investigation to understand 
their role in the pathogenesis of corneal astigmatism. Finally, 
exploiting the recently introduced LD score regression tech-
nique, we estimated the SNP heritability of corneal astigma-
tism (and refractive astigmatism) to be much lower than that 
for spherical equivalent refractive error (Table 3) [51]. This 
implies that astigmatism must be under greater influence 
of rare genetic variants or environmental risk factors than 
spherical equivalent or that the common genetic variants that 
contribute to astigmatism have non-additive effects.
APPENDIX 1. INSTRUMENT FOR MEASURING 
CORNEAL CURVATURE.
To access the data, click or select the words “Appendix 1”
APPENDIX 2. MANHATTAN PLOTS FOR THE 
SEPARATE ANCESTRY/AGE STRATA FIXED 
EFFECTS META-ANALYSES.
Manhattan plots for the separate ancestry/age strata fixed 
effects meta-analyses. Y-axes show negative log
10
 p-values 
and X-axes show genomic position. Red line corresponds to 
P = 5 x 10-8, blue line corresponds to P = 1 x 10-5. Panel A, 
European ancestry, aged >25 years; B, European ancestry, 
aged <25 years; C, Asian ancestry, aged >25 years; D, Asian 
ancestry, aged <25 years. To access the data, click or select 
the words “Appendix 2”
APPENDIX 3. QUANTILE-QUANTILE PLOTS FOR 
THE SEPARATE ANCESTRY/AGE STRATA FIXED 
EFFECTS META-ANALYSES.
Y-axes show observed negative log
10
 p-values and X-axes 
show expected negative log
10
 p-values according to the null 
hypothesis of no genetic association. Red line is the line of 
unity (y = x). Panel A, European ancestry, aged >25 years; B, 
European ancestry, aged <25 years; C, Asian ancestry, aged 
>25 years; D, Asian ancestry, aged <25 years. To access the 
data, click or select the words “Appendix 3”
APPENDIX 4. MOST STRONGLY ASSOCIATED 
MARKER IN EACH REGION IN THE GWAS META-
ANALYSIS OF ALL EUROPEANS AGED >25 YEARS.
To access the data, click or select the words “Appendix 4”
APPENDIX 5. MOST STRONGLY ASSOCIATED 
MARKER IN EACH REGION IN THE GWAS META-
ANALYSIS OF ALL EUROPEANS AGED <25 YEARS.
To access the data, click or select the words “Appendix 5”
APPENDIX 6. MOST STRONGLY ASSOCIATED 
MARKER IN EACH REGION IN THE GWAS META-
ANALYSIS OF ALL ASIANS AGED >25 YEARS.
To access the data, click or select the words “Appendix 6”
APPENDIX 7. MOST STRONGLY ASSOCIATED 
MARKER IN EACH REGION IN THE GWAS META-
ANALYSIS OF ALL ASIANS AGED <25 YEARS.
To access the data, click or select the words “Appendix 7”
APPENDIX 8. TOP 10 GENES FROM VEGAS2 GENE-
BASED ASSOCIATION TEST WITH ±50KB BUFFERS 
FOR ALL EUROPEANS.
Start and stop positions listed include ±50kb buffers. nSNPs: 
number of variants included in gene region. Test Statistic: 
gene-based χ2 test statistic to nSNPs degrees of freedom. 
P-value: obtained from Test Statistic and adjusting for LD 
between variants. FDR: false discovery rate (likelihood of 
gene association being a false positive result). Top SNP: 
variant within gene locus with strongest association signal 
from previous SNP-based association test. Genes shown in 
bold were also identified with MAGMA (Appendix 9). To 
access the data, click or select the words “Appendix 8”
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APPENDIX 9. TOP 10 GENES FROM MAGMA GENE-
BASED ASSOCIATION TEST WITH ±50KB BUFFERS 
FOR ALL EUROPEANS.
Start and stop positions listed include ±50kb buffers. nSNPs: 
number of variants included in gene region. Z Statistic: gene-
based test statistic. P-value: obtained from Z Statistic under 
the assumption of a normally distributed model. FDR: false 
discovery rate (likelihood of gene association being a false 
positive result). Genes shown in bold were also identified 
with VEGAS2 (Appendix 8). To access the data, click or 
select the words “Appendix 9”
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